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Derivation of Induced Pluripotent Stem Cells from Rat Primary Cells Utilising 
the Cre-Lox Lentiviral Delivery System 
 
Abstract: 
Somatic cells can be reprogrammed to an embryonic stem cell-like state, regaining the 
ability to differentiate into any cell in the body. Induced pluripotent stem cells (iPSCs) 
can be derived through the delivery and expression of exogenous transcription 
factors; Oct4, Sox2, Klf4 and c-Myc being the original and most commonly used. The 
project utilised the STEMCCA virus, a lentivirus delivery system comprising of all four 
reprogramming factors in a single cassette. Different media and culturing conditions 
were used in an attempt to derive rat iPSCs from adipose- and dental pulp derived 
stem cells (ADSCs and DPSCs, respectively). Staining for alkaline phosphatase, which is 
highly expressed in ESCs and iPSCs, was used to demonstrate whether colonies 
observed were potentially composed of iPSCs. Initial attempts using iPSC media, a 
feeder layer or ascorbic acid and lithium chloride supplementation, were unsuccessful 
in generating iPSC colonies. Medium supplemented with two inhibitors, CHIR-99021 
and PD-0325901, was successful in generating iPSC colonies with an ESC-like 
morphology from rat embryonic fibroblasts.  iPSC colonies failed to form using the 
same culture conditions with the ADSCs and DPSCs.  
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1. Introduction 
 
Stem cells have the potential to regenerate and repair tissues whilst being able to self-replicate, 
which has led to scientists exploiting them to develop therapies, however not all stem cells are the 
same or have the same capacity to regenerate and repair tissues.  
During development cells become increasingly committed to specific lineages; upon fertilisation until 
the 8-cell stage, cells of the developing embryo are totipotent due to their capacity to differentiate 
into both embryonic and extraembryonic tissues[1]. The embryo continues through several more cell 
divisions to the morula stage and then forms the blastocyst which consists of the trophoblast, inner 
cell mass (ICM) and blastocoele (Fig. 1). The blastocyst marks an early stage whereby cells commit to 
a specific lineage; cells of the ICM commit to give rise to the embryo and the trophoblastic cells 
become committed to form extraembryonic tissues, such as the placenta, which will support the 
development of the growing embryo. The cells of the ICM are pluripotent as they are able to 
differentiate into any cell from the three germ layers; the ectoderm which gives rise to the nervous 
system and epidermis; mesoderm which generates of the muscle, heart and blood; and the 
endoderm which forms of the lungs, gastrointestinal tract, endocrine organs and bladder.  
Cells of the developing embryo become increasingly specialised and committed to specific lineages. 
Other than totipotent and pluripotent, cells can be termed multi-, omni- or uni- potent depending 
on their capacity to differentiate into different cell types. Adult stem cells, such as haematopoietic 
and neural stem cells, are traditionally defined as multipotent as they can form all the cells of that 
specific lineage but are unable to form cells from different germ layers. However some cells such as 
mesenchymal stem cells are challenging the traditional definitions of cell potency due to being able 
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to differentiate and form cells from different germ layers[2-4]. Omnipotent cells have a restricted 
potential to differentiate into just a few cell types from a specific lineage whereas unipotent cells are 
only able to give rise to one cell type. The reduction in cell potency is concurrent with the acquisition 
of epigenetic changes, such as methylation of gene promoters, which are responsible for the stem 
cell state or lineage specification[5].  
 
Figure 1: Overview of mammalian development. Diagram shows the crucial stages of development, 
the stages pluripotency and developmental associated genes are expressed and the global 
epigenetic patterning. ESCs can be successfully isolated from the inner cell mass of the blastocyst. 
Global hypomethylation is present from the zygotic to morula stage, which corresponds to 
expression of pluripotency associated genes.  Epigenetic changes are accumulated, downregulating 
pluripotency associated genes which results in developmental associated genes being expressed. 
Image adapted from Reik et al., (2007)[5]. 
 
The pluripotent cells from the ICM, otherwise known as embryonic stem cells (ESCs) have been 
successfully isolated and cultured[6-8], which raises the possibility of them being used therapeutically 
for regenerating and repairing damaged tissues due to their ability to self-replicate and potentially 
form any cell in the body. However ethical and safety concerns regarding the use of human embryos, 
Blastocyst
Trophoblast
(Pluripotent)
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and the potential for teratoma formation have limited their application. Ensuing research found that 
somatic cell nuclear transfer (SCNT), a technique whereby somatic cell nuclei are injected into 
enucleated oocytes, could generate pluripotent ESC-like cells from somatic cells[9, 10]. The importance 
of this discovery was that somatic cells not only retained the ability the form other cells but could 
also be reprogrammed back to a pluripotent state. However, the utility of SNCT for therapeutic 
purposes may be limited due to opposition to human cloning, the labour intensive nature of the 
derivation of ESC-like cells and, up to this point, the human ESC-like cells created being triploid[9].   
The recent discovery that somatic cells can be reprogrammed into pluripotent cells with the addition 
of four transcription factors has ignited an interest in using these cells for therapeutic purposes (Fig. 
2). Yamanka and Takahashi were able to create ESC-like cells from mouse embryonic fibroblasts 
(MEFs) using retroviruses to deliver a cocktail of candidate transcription factors[11], which had 
previously been shown to either be highly expressed in ESCs or important for their derivation or 
maintenance[12-17]. Systematic screening of the 24 candidate genes used identified that four factors; 
Oct4, Sox2, Krüppel like factor 4 (Klf4) and c-Myc, were required to reprogram a somatic cell to an 
ESC-like state. The cells that had been reprogrammed to an ESC-like state were termed induced 
pluripotent stem cells (iPSCs). iPSCs were characterised and shown to express embryonic genes 
important in maintaining pluripotency and at a similar level to ESCs. The iPSCs were demonstrated, 
by transplantation into nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, to 
have the ability to form cells from all three germ layers. The initial paper by Takahashi and Yamanaka 
was unable to show iPSCs could contribute to chimera formation, however subsequent studies have 
confirmed pluripotency by demonstrating the generation of chimeras from iPSCs, moreover they 
have shown iPSCs could contribute to the germ line[18, 19].  
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Figure 2: Reprogramming of somatic cells to iPSCs. Somatic cells (fibroblasts) can be reprogrammed 
using the four factors, Oct4, Sox2, Klf4 and c-Myc to generate iPSCs. iPSCs have the potential to 
differentiate into any somatic cell. Figure taken from Nsair et al., (2011)[20]. 
Subsequent studies have derived iPSCs from different tissues, species, and using different methods. 
Initial iPSC derivation utilised genetically modified retroviruses[11, 21] and lentiviruses[22-24] to deliver 
the reprogramming factors, however concerns arose regarding the use of viruses if iPSCs were to be 
used therapeutically. Reprogramming via retroviruses and lentiviruses requires viral genes being 
integrated into the genome which could potentially cause aberrant mutations[25, 26]; the viral genes 
have also been shown to be persistently expressed albeit at low levels[27].  
To overcome these obstacles scientists have modified different viruses to deliver the reprogramming 
factors. Adenoviruses and Sendai viruses have been used to deliver the reprogramming factors due 
to their advantage of not integrating into the genome. However they also have disadvantages such 
as a lower efficiency of reprogramming in the case of adenoviral vectors (0.001% opposed to up to 
1%) and difficulty in removing all the Sendai viruses from the cells[27]. Others have developed 
excisable vectors, such as loxP-flanked lentiviral cassettes[28, 29] or transposons[30-32], which allow for 
the inducing genes to be removed after reprogramming, the disadvantage being the labour intensive 
screening required to verify successful removal of the vector. More recently, protocols have been 
developed to derive iPSCs using either proteins[33, 34], modified mRNA[35] or microRNAs[36, 37]. These 
Reprogramming
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have the benefits of not having genomic integration and thus being therapeutically more relevant, 
however have a lower efficiency of generating iPSCs (efficiency of approximately 0.001-0.1%).  
1.1 Reprogramming: The Factors and Mechanism 
 
Originally, iPSCs were generated using the four factors Oct4, Sox2, Klf4 and c-Myc (OSKM)[11]. 
Developments in the reprogramming field have shown that not all of the OSKM factors are required 
for reprogramming, with all four able to be replaced to some extent. c-Myc was initially removed 
due to being an oncogene and found not to be critical for the generation of iPSCs, but rather 
increased the efficiency of derivation[38, 39]. Sox2 and Klf4 can be replaced with other factors or 
excluded altogether, however the efficiency of iPSC derivation is reduced[40-42]. The cell type used to 
derive iPSCs is important as factors can be removed if expressed endogenously, for example neural 
stem cells only require the transduction of Oct4 to be reprogrammed as they already express 
Sox2[41]. Oct4 has been described as the key factor that could not be replaced when reprogramming 
cells, however it was discovered that Nr5a2 can replace Oct4 [43]. Nanog, lin28, as well as other 
factors from the Sox, Klf and Myc family have also been used to reprogram somatic cells to iPSCs[38, 
44, 45].  
Reprogramming involves the downregulation and cessation of the somatic cell program and an 
induction and upregulation of the embryonic or pluripotency program. Somatic cell specific genes 
such as Thy-1 are downregulated and silenced and ESC genes such as stage specific embryonic 
antigen-1 (SSEA-1), alkaline phosphatase, Oct4 and nanog are upregulated[24, 46]. The OSKM 
reprogramming factors have been demonstrated to play different roles in reverting somatic cells 
back to an ESC-like state[47]. c-Myc was found to confer the most ESC-like expression changes 
required for reprogramming, even though it is not essential for reprogramming. c-Myc is able to 
repress the expression of somatic specific genes, which may be brought about by c-Myc binding to 
Mix-1 and repressing its activity. The c-Myc/Miz-1 complex has also been shown to recruit 
methyltransferases and deacetylases to gene promoters, which as explained later is important in 
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reprogramming, as well as repressing genes important in differentiation, most notable being the Hox 
genes[48]. OSK plays a greater role in activating ESC specific genes through binding to gene 
promoters. OSK have been shown in ESCs to co-occupy ESC specific genes, including their own 
promoters, and the same is believed to be true in iPSCs and reprogramming[49-52]. Oct4, a product of 
the POU5f1 (POU domain, class 5, transcription factor 1) gene, is essential to establish and maintain 
pluripotency [15]. The level of Oct4 needs to be tightly regulated to maintain pluripotency as low 
levels, excessive levels or no Oct4 can cause cells to lose their potency and differentiate[53].  Nanog is 
also important for maintaining the pluripotency of cells, however was found to be redundant in 
reprogramming cells to a pluripotent state[11]. 
Reprogramming also involves global epigenetic remodelling, which contributes to the 
downregulation of somatic genes and upregulation of ESC genes[5]. Histone methylation changes in 
ESC specific genes have been demonstrated during reprogramming, with histone H3 K27 
trimethylation (lysine 27; a repressive mark) being replaced with the activating histone H3 K4 
trimethylation mark(Fig. 1)[47]. iPSC generation can be promoted by using inhibitors of epigenetic 
enzymes such as valproic acid, a histone deacetylase inhibitor[54, 55]. The histone modifications are 
important in reprogramming as is the methylation status of promoters, with ESC gene promoters 
becoming demethylated allowing for transcription factors to bind and induce expression[21]. iPSCs 
and ESCs have similar global epigenetic patterning, however iPSCs retain epigenetic marks 
associated with the cells they were derived from[56]. Furthermore, this retention of somatic cell 
epigenetic marks has been shown to have an effect of iPSC differentiation, with a bias found towards 
differentiating along the lineage of derivation, however this can be mitigated by passaging iPSCs in 
vitro[57].  
1.2 Derivation of iPSCs from different species 
 
Since the original derivation of iPSC from MEFs, iPSCs have been generated from numerous different 
species including humans[21] ; non-human primates such as the rhesus macaque (Macaca 
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mulatta)[58]; domestic animals and livestock including  pigs[59, 60] and sheep[61]; and endangered 
animals with two examples being the drill (Mandrillus leucophaeus) and the northern white 
rhinoceros (Ceratotherium simum cottoni)[62].  Derivation of iPSCs from different species has 
required the modification and development of culture and induction techniques to support iPSC 
formation. Human iPSCs (hiPSCs) were generated from adult fibroblasts using the same factors for 
mouse iPSC (miPSC) derivation, however required basic fibroblast growth factor (bFGF) rather than 
leukaemia inhibitory factor (LIF) to be supplemented to the culture media[21]. Derivation of hiPSCs 
also utilises media which has been developed to support the growth of ESCs, and therefore iPSCs, 
over the growth of somatic cells. iPSCs from other species requires the culturing conditions to be 
optimised and modified to support their growth. Due to the high conservation of the reprogramming 
factors the majority of iPSCs are reprogrammed using either the mouse or human genes.   
1.3 Derivation of rat iPSCs 
 
Derivation of rat iPSCs (riPSCs) has been a goal for research groups ever since miPSCs were 
generated. This is due to the rat being a valuable model organism for the study of human diseases 
like diabetes and hypertension as well as being important for the testing of regenerative 
therapies[63]. The derivation of riPSCs thus allows for easier production of genetically modified rats as 
well as being able to test the therapeutic suitability of iPSCs in rat models. riPSCs have been 
generated by only a few groups and have been generated from rat embryonic fibroblasts (REFs)[19, 64], 
adult rat fibroblasts[63], the rat cell line WB-F344[65] and rat neural precursor cells[66], however they 
have never been generated from dental pulp stem cells (DPSCs) or adipose derived stem cells 
(ADSCs).  
1.4 Culture media development 
 
The culture media iPSCs are cultured and reprogrammed in has a large impact on the success and 
efficiency of derivation. Small molecules have been used to improve the efficiency of reprogramming 
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which include inhibitors of differentiation pathways such as the glycogen synthase kinase 3β (GSK3β) 
inhibitor CHIR99021, the MAPK/ERK (MEK) inhibitor PD0325901 or TGFβ inhibitors; and small 
molecules that affect epigenetic marks such as valproic acid, 5’ azacytidine, BIX-01294[67]. Others 
found the addition of ascorbic acid (vitamin C)[55] or lithium (in the form of lithium chloride)[68] 
facilitated reprogramming and therefore increased the efficiency of iPSC derivation. Ascorbic acid 
was demonstrated to alleviate cell senescence by downregulating p53[55] as well as promoting the 
transition of pre-iPSCs – cells which have ESC-like morphology but fail to completely activate 
pluripotency genes and cannot form chimeras[69] – into fully fledged iPSCs. Lithium prevents 
differentiation by inhibiting GSK3β, however culturing with CHIR99021 gives further improvements 
in efficiency suggesting lithium has other hitherto unknown roles in reprogramming[68]. Systematic 
screening of chemical compounds has been performed and used to develop media that can improve 
the efficiency and quality of iPSCs derived[70].  
1.5 Reprogramming of adipose and dental pulp derived stem cells 
 
Dental pulp and adipose tissue encompass a population of mesenchymal stem cells, which have 
increased the interest in the tissues. Adipose and dental pulp are easily available due to being in 
relatively high abundance owing to the loss of deciduous teeth, routine extraction of 3rd molars and 
the increasing application , especially in developed countries, of lipoaspiration (liposuction). 
Furthermore, adipose derived and dental pulp derived stem cells (ADSCs and DPSCs respectively) 
have been shown to be easier to reprogram with a greater efficiency of iPSC generation when using 
comparable transduction and culturing conditions[71, 72]. This is thought to be due to stem cells being 
more plastic than fully differentiated cells, therefore less reprogramming is required to revert a stem 
cell back to a pluripotent cell. Moreover, stem cells have also been shown to express genes required 
for maintaining or inducing pluripotency, for example, DPSCs have been revealed to express Oct4, 
Sox2 and c-Myc.  
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1.6 Aim of project 
 
The aim of the project was to generate stable rat iPSCs from postnatal dental pulp and adipose cells 
using the Cre-lox lentiviral delivery system (Fig. 3) and to characterise them. riPSCs have not been 
generated from dental pulp or adipose tissue before and the STEMCCA (“stem cell cassette”) has not 
previously been utilised to generate riPSCs.  
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2. Methods 
 
2.1 Cell Culture 
 
2.1.1 Adipose and Dental Pulp Stem Cells 
 
ADSCs and DPSCs were harvested from the same six week old Wistar-Hann rats. ADSCs were isolated 
by digesting the inguinal fat pads in collagenase (8 mg collagenase (C1764, Sigma), 160 mg bovine 
serum albumin (A2153-100G, Sigma) and 8 ml phosphate buffered saline (PBS)) for 30 mins at 37 °C. 
α-MEM (LM-E1148/500, Biosera) with 20% foetal calf serum (FCS; A2153, Sigma) was added to the 
mixture to stop the reaction and then passed through a cell sieve. The mixture was then spun at 180 
rcf for 5 mins; the pellet resuspended in 1 ml α-MEM with 20% FCS and then filtered through a 70 
µm cell strainer. ADSC were cultured in T75 flasks in isolation media; α-MEM (Biosera), with 20% FCS 
and 1% penicillin/streptomycin (15070, Gibco). DPSCs were isolated from the dental pulp of the 
incisors of two rats (8 teeth in total). The dental pulp was removed using tweezers and then minced 
using a scalpel, wherein the pulp was digested in 4 ml 1x trypsin-EDTA (25200, Gibco) for 30 mins at 
37 °C, after which the trypsin was quenched by adding 4 ml of isolation media. The digested mixture 
was then passed through a cell filter, pelleted by centrifugation at 180 rcf and the pellet 
resuspended in isolation media then cultured in a T25 flask. ADSC and DPSC were cultured in a 
humidified incubator at 37 °C in 5% CO2 and used at passage 2 or 3.  
2.1.2 Rat Embryonic Fibroblasts (REFs) 
 
REFs were prepared by digesting E14.5 embryos in trypsin after removing the foetal heart, liver and 
cerebellum[11, 18]. Initially, the embryo was digested in 3 ml 1x trypsin-EDTA (15400-054, Gibco) for 30 
mins at 37 °C with regular agitation. Subsequently, the embryos were digested in 6 successive 
rounds of 15 mins digestions at 37 °C with 1.5 ml of digested tissue removed and 1.5 ml 1x trypsin 
was replaced each iteration. Trypsin was inactivated using REF media (DMEM (41965, Gibco) 
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supplemented with 10% FCS (Sigma), 1% penicillin and streptomycin (Gibco), 2 mM L-glutamine 
(25030, Gibco) and 0.1 mM β-mecaptoethanol (M7522, Sigma)). The digested mixture was 
centrifuged at 218 rcf and the pellet and filamentous material resuspended in REF media. REFs were 
cultured in T75 flasks at 37 °C in a humidified incubator. REFs were used at passage 1.  
2.2 Viral Titration 
 
293T-HEK cells[73]– human embryonic kidney cell line that is highly transfectable - were seeded at a 
density of 1 x 106 per well in five wells in a six well plate and cultured in T-HEK medium (DMEM, 10 % 
Foetal bovine serum, 1 % penicillin/streptomycin and 2 mM L-glutamine). 293T-HEK cells were 
cultured in 5% CO2 at 37 °C for 24 hours before being gently washed with PBS. Cells from one well 
were removed by digesting with 1x trypsin-EDTA and counted using a haemocytometer to determine 
the number of cells present for the titration. The remaining four wells were used for the viral 
titration and to each well 1 ml of media with polybrene (107689, Sigma; increases the infectability of 
cells). The ZsGreen virus, a virus genetically modified to produce green fluorescent protein (GFP), 
was used for the titration as the STEMCCA virus does not contain a fluorescent marker that could be 
used to determine the titres. The concentrated ZsGreen virus was diluted in media and polybrene to 
a tenth and a hundredth of the concentration. 1 µl of the concentrated and diluted virus was added 
individually to three wells, the fourth well was used as an uninfected control. The infection was 
stopped by replacing the media devoid of polybrene 20 hours after the initial infection. The T-HEK 
media was replaced every day. The cells were cultured for a total of 72 hours post-infection before 
being washed with PBS and removed using 1x tryspin-EDTA. Flow cytometric analysis was used to 
determine whether the cells had been infected, which was used to calculate the titres.  
The titres were calculated using the formula:  
 
xNumber of cells at 
time of infection
% of cells GFP 
positive
Number of virions per volume 
of virus added to the well 
=
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The average virions per volume was then calculated for the ZsGreen virus and multiplied by the 
number of virions required to infect 1 x 105 with a multiplicity of infection (MOI) of 1 (1x105 cells 
with a MOI of 1 equals 1x105 virions deposited). The MOI is the number of virions required to infect 
a set proportion of cells. The STEMCCA virus has a lower efficiency of infecting cells that the ZsGreen 
virus, therefore a conversion factor of x20 was used to calculate the volume of STEMCCA virus that is 
required to infect 1x105 cells with a MOI of 1 from the ZsGreen results.  
2.3 Reprogramming 
 
The project utilised a single lentivirus stem cell cassette delivery system, which had been developed 
to deliver all four reprogramming factors (OSKM) in a single integration. Efficient reprogramming 
using the STEMCCA ("stem cell cassette") virus is achieved due to the design of the STEMCCA 
cassette which produces OSKM factors with a stoichiometry (ratio to one another) that favours 
reprogramming. The reprogramming cassette becomes flanked by loxP sites during integration 
which allows for Cre recombinase mediated removal of the cassette following iPSC derivation.  
 
Figure 3: Schematic diagram showing the inducible STEMCCA developed by Sommer et al., 
(2009)[29]. The STEMCCA virus used to transduce the cells in the project did not contain the inducible 
TetO element. The Oct4 and KLF4 and; Sox2 and c-Myc genes are separated by F2A and E2A 
sequences respectively which encode self-cleaving peptides. The 2A peptides allow for post-
translational cleavage of the two proteins, which improves the levels of protein produced from the 
cassette. Abbreviations: LTR, long terminal repeat; PSI, packaging signal; RRE, rev responsive 
element; HIV, Human immunodeficiency virus; cpPU, central polypuryne tract; miniCMV, mini-
cytomegalovirus; IRES, internal ribosome entry site; WPRE, woodchuck hepatitis virus post-
translational regulatory element; dU3, deleted U3. 
5’ LTR PSI RRE
HIV cpPu
TetO
miniCMV
Oct4
F2A
Klf4
IRES
Sox2
E2A
cMyc
WPRE
dU3
3’ LTR
STEMCCA
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All cells prior to reprogramming were checked for mycoplasma using the MycoAlert kit (LT07, Lonza), 
as mycoplasma can influence stem cell behaviour and viability[74]. ADSC, DPSC and REFs were seeded 
on 0.1% gelatinised plates at a density of 1x105 cells per well in a six well plate the day before the 
intended infection and grown in their respective media (Fig. 4, A). On the day of infection the media 
was removed, the cells were washed with PBS and the medium replaced with the addition of 
polybrene; the STEMCCA virus was added to the cells at a MOI of 1. The following day the medium 
was removed to stop the infection and replaced with iPSC media; DMEM supplemented with 15% 
Hyclone ESC qualified FBS (03147, Thermo Scientific), 1 % penicillin/streptomycin (5000 units ml-1), 2 
mM L-glutamine, 0.1 mM β-mecaptoethanol and 0.01 % mouse LIF (1 x 106 units ml-1; ESG1106, 
Millipore). The iPSC media was modified for some culture experiments with the addition of other 
compounds which include 50 µg ml-1 ascorbic acid (A4544, Sigma), 10 mM lithium chloride (L9650, 
Sigma) and the inhibitors CHIR-99021 (S1263-SEL, Stratech Scientific) at 3 µM and PD-
0325901(S1036-SEL, Stratech Scientific) at 0.5 µM. The inhibitors when used together are known as 
2i. Cells were cultured in iPSC medium until iPSC colonies were established.  
Another method of iPSC derivation was performed which utilised a feeder layer of gamma irradiated 
MEFs and ESC media(Fig. 4, B). ADSC and DPSCs were infected with the STEMCCA virus and grown in 
iPSCs media as previously described. Five days post-transduction the infected ADSCs and DPSCs were 
washed with PBS and removed from the culture dish using 1x trypsin-EDTA. Cells were then seeded 
onto either the gamma-irradiated MEF feeder layer which had been seeded onto gelatinised 6 well 
plates the day before, or onto gelatinised 6 well plates devoid of irradiated MEFs. The medium at 
this point was changed to ESC media which consists of 410 ml knockout DMEM (10829, Gibco), 5 ml 
L-glutamine, 5 ml penicillin/streptomycin, 5 ml non-essential amino acids (M7145, Sigma), 75 ml 
knockout serum replacement (10828-028, Invitrogen), 50 µl LIF and 3.5 µl β-mecaptoethanol, as ESC 
media should support the growth of iPSCs.   
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Figure 4: Schematic diagram showing the transduction time schedule and the media used. A, 
Example of method to derive iPSCs without re-seeding on feeder layer; B, method used to generate 
iPSCs using ESC media and an irradiated MEF feeder layer[21, 66]. Medium for initial culture was that 
suited to the cells being cultured, with REF media being shown as an example in the schematic 
diagram.  
2.4 Alkaline Phosphatase staining 
 
Media was removed from the presumptive iPSCs, rinsed with cold PBS and then fixed in cold 10% 
neutral formalin buffer (16g Na2NPO4, 4g Na2HPO4.H20, 1 L distilled water and 16 % formaldehyde 
methanol free) for 15 mins. The neutral formalin buffer was removed and the cells washed with cold 
distilled water and remained in cold distilled water for 15 mins. The distilled water was then 
removed and the substrate solution added and left at room temperature for 45 mins. The substrate 
solution consisted of 0.0025 g Naphtol AS MX-PO4 (N5000, Sigma)  dissolved in 100 µl N,N-
dimethylformamide (D4551, Sigma)  mixed with 12.5 ml 0.2M pH 8.3 Tris-HCl and 12.5 ml distilled 
water; fast red violet LB salt (F1625, Sigma) was then added to the mixture then filtered using 
Whatman’s No. 1 filter paper. The substrate solution was then removed and rinsed with distilled 
water. Red staining indicates the presence of alkaline phosphatase; a marker for iPSCs.  
2.5 DNA extraction  
 
DNA was extracted from the excess cells from the feeder layer transfection protocol using the TRIzol 
extraction method. Briefly, cells were pelleted and then homogenised in 0.5 ml TRIzol reagent 
(15596, Gibco). 150 µl of 100% ethanol was then added and the tubes inverted to mix the reagents. 
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The samples were incubated at room temperature for 2-3 mins and then centrifuged at 2000 x g for 
5 mins at 4 °C to pellet the DNA. The pellet was then washed with 0.5 ml sodium citrate/ethanol 
solution (0.1 M sodium citrate in 10% ethanol, pH 8.5) and incubated for 30 mins at room 
temperature with occasional inversion. The mixture was then centrifuged at 2000 x g for 5 mins at 4 
°C and the supernatant then removed. This was repeated and then 1 ml of 75% ethanol added and 
the sample incubated for 20 mins at room temperature with the occasional inversion. The sample 
was then centrifuged at 2000 x g for 5 mins at 4 °C and the supernatant discarded, after which the 
DNA pellet was left to air dry for 5 to 10 mins. The DNA was resuspended in 10 µl of 8 mM NaOH and 
quantified using a Nanodrop (Thermo Scientific).   
2.6 Polymerase Chain Reaction (PCR) 
 
PCR was used to check that the STEMCCA cassette had been inserted into the genome. 12 ng of DNA 
was added to 22.7 µl of PCR Reddymix plus (AB-0608/LD, Thermo Scientific) and the volume 
made up to 25 µl using PCR water. The primers used were; miPSt-CreEx-F, 
GAAACTCTGGTGCATAAATCGATAG and miPSC-CreEx-R, GGAGGCGGCCCAAAGGGAGATCCG. The 
conditions of the PCR reaction were 95 °C for 3 mins, 94 °C for 30 secs, 60 °C for 30 secs, 72 °C for 
1.5 mins, 40 cycles and a final heat of 72 °C for 5 mins. The PCR product was analysed by running on 
a 1.5 % agarose gel containing ethidium bromide for 2 hours at 100 V and then visualised using a Gel 
Doc XR+ (Bio Rad).  
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3. Results 
 
3.1 Viral titration 
 
A viral titration was initially performed to determine the amount of STEMCCA virus that would be 
used for the transduction. 293T-HEK cells were infected with the ZsGreen virus as a surrogate for the 
STEMCCA virus due to the ZsGreen virus expressing GFP and therefore allowing for cells infected 
with the virus to be determined using flow cytometry. 293T-HEK cells were infected with different 
concentrations of the ZsGreen virus (1 µl of concentrated virus (1 C) and a tenth (0.1 C) and 
hundredth (0.01 C) of this concentration), as well as control 293T-HEK cells that were not infected 
with the virus. Cells were analysed by forward scatter (FS; corresponds to cell volume) and side 
scatter (SS; indicates complexity or granulation of a cell) to select for alive cells (Fig. 5, A). These cells 
were gated and analysed for the expression of GFP (shown by FITC log on y-axis, Fig. 5, B). The no 
virus control was used to determine the gating that would be used to signify whether a cell had been 
infected with the ZsGreen virus (Fig. 5, Bi). The analysis showed the 90.07 % of cells were infected 
when 1 C of ZsGreen virus was used, 15.27 % with 0.1 C and 4.93 % with 0.01 C. These percentages 
of infection were then used to determine the number of virions per volume of virus added with the 
average being calculated to be 5.4x109 virions ml-1. It was then calculated that to infect 1x105 cells 
with a MOI of 1, 0.0185 µl of concentrated ZsGreen virus was required.  This was converted to the 
volume of STEMCCA virus required by multiplying by 20, giving 0.371 µl.  
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3.2 Initial transduction using iPSC media 
 
ADSCs, DPSCs and MEFs were infected with the STEMCCA virus at a MOI of 1 and then cultured in 
iPSC media. MEFs which were used as a positive control formed iPSC colonies (Fig. 6), which can be 
seen by their morphology; "dome shaped and refractile colonies"[27], by day 6 (Fig. 6, E) and the 
colonies remained to day 10 (Fig. 6, F). The ADSCs and DPSCs were observed to form colonies on day 
10 (Figs. 7, F and 8, C and F), however did not have the morphology of iPSC colonies and in the case 
of the DPSCs similar colonies were observed on the control culture which had not been infected with 
No Virus 0.01 C
0.1 C 1 C
A B i ii
iii iv
Figure 5: Flow cytometric analysis of 293T-HEK cells infected with ZsGreen virus to determine the 
quantity of STEMCCA virus required to transduce cells. A; Density plot showing an example of the 
gating (R1) used to select cells for further analysis. B; Plots showing the gating (R3) used to determine 
the percentage of cells infected with the ZsGreen virus. Plots shown for 293T cells infected with no 
virus (i), 0.01C (ii), 0.1C (iii) and 1C (iv) virus. The ZsGreen virus fluoresces green when stimulated 
with a 488 nm laser and the level of fluorescence is measured by FITC log (y-axis). Each dot on the 
density plot represents a cell; the colour denotes the number of cells in an area (red, low density; 
yellow, high density).  
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the STEMCCA virus (Fig. 8, C). The colonies observed on day 10 remained until day 20 (Figs. 7 and 9, 
H and K); in this time no colonies with an iPSC morphology were formed. Verification, by staining for 
alkaline phosphatase confirmed that the colonies formed were not iPSCs (Figs. 7 and 8, H and K). The 
DPSCs stained moderately for the expression of alkaline phosphatase, regardless of whether the cells 
had been transduced or not (Fig. 8, H, I, K, and L). The ADSCs did not stain for alkaline phosphatase, 
however the majority of cells detached from the culture dish prior to fixing and staining. Transduced 
ADSCs and DPSCs were also cultured in DMEM based iPSC media with similar results observed (Figs. 
S1 and S2) 
 
 
A B C
D E F
Figure 6: MEFs transduced with the STEMMCCA virus and cultured in iPSC medium. A-C, Control 
MEFs which were not transfected with the STEMCCA virus; D-F, MEFs infected with the STEMCCA 
virus. Images show transduced cells at days 4 (A and D), 6 (B and E), and 10 (C and F). Arrows indicate 
iPSC colony formation and scale bars represent 100 µm. 
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Figure 7: ADSCs transduced with the STEMMCCA virus and cultured in iPSC medium containing α-
MEM. A-C, G and H, Control ADSCs that were not transfected with the STEMCCA virus; D-F, J and K, 
ADSCs when infected with the STEMCCA virus. Images show transduced cells at days 4 (A and D), 6 (B 
and E), 10 (C and F) and 18 (G and J). ADSCs were stained for alkaline phosphatase on day 20 (H and 
K).  Scale bars represent 100 µm. Arrows indicate colonies which formed. Plates stained with alkaline 
phosphatase are not shown due to cells dissociating from culture dish.  
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3.3 Feeder layer reprogramming method 
 
Reprogramming using iPSC media failed to generate iPSC colonies from DPSCs and ADSCs therefore 
an alternative method used to derive iPSCs was performed(See Fig. 4). For the alternative 
reprogramming method, ADSCs and DPSCs were seeded onto an irradiated MEF feeder layer 5 days 
post-transduction and the media was changed to ESC media, which promotes the growth of ESCs 
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Figure 8: DPSCs transduced with the STEMMCCA virus and cultured in iPSC medium containing α-
MEM. A-C and G-I, Control DPSCs; D-F and J-L, Transduced DPSCs. Images show transduced cells at 
days 4 (A and D), 6 (B and E), 10 (C and F) and 18 (G and J). DPSCs were stained with alkaline 
phosphatase on day 20 (H, I, K, and L).  Scale bars represent 100 µm for A-H, J and K and 1 cm for I 
and L. Arrows indicate colony formation.  
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and iPSCs rather than somatic cells. ADSCs seeded onto the irradiated MEF feeder layer failed to 
form any colonies (Fig. 9), whereas the DPSCs initially formed colonies (Fig. 10, D and E) which did 
not establish into iPSC colonies (Fig. 10, F, I and J). Staining for alkaline phosphatase confirmed that 
no iPSC colonies had formed (Fig. 9 and 10 G-J), however some cells showed expression of alkaline 
phosphatase (Fig. 9  and 10, G and I). Cells were also cultured in ESC media but were not seeded 
onto an irradiated MEF feeder layer (Figs. S3 and S4). These cultures also failed to derive riPSCs from 
ADSCs and DPSCs.  
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Figure 9: ADSCs infected with the STEMCCA virus and seeded on an irradiated MEF feeder layer. A-
C, G and H, Control ADSCs; D-F, I and J, ADSCs infected with the STEMCCA virus.  ADSCs were seeded 
on the irradiated MEF feeder layer on the 5th day post-infection. Images are from day 7 (A and D), 
day 9 (B and E), day 14 (C and F) and the cultures were stained on day 21 for alkaline phosphatase (G-
J). Scale bars represent 100 µm (A-G and I) and 1 cm (H and J). 
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Figure 10: DPSCs cultured on an irradiated MEF feeder layer post-infection with the STEMCCA virus. 
A-C, G and H, Control DPSCs not infected with the STEMCCA virus; D-F, I and J, Transduced DPSCs. 
Images taken on day 7 (A and D), day 9 (B and E), day 14 (C and F) and the cultures were stained on 
day 21 for alkaline phosphatase (G-J). Arrows indicate colonies and scale bars represent 100 µm (A-G 
and I) and 1 cm (H and J) 
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DNA from spare cells not required for the re-seeding onto the feeder layer was isolated and used to 
check that the STEMCCA had been inserted into the genome. PCR confirmed the presence of the 
STEMCCA cassette in the virally infected cells (Fig. 11). The band observed of the virally infected 
ADSCs was weak, which was probably due to the poor quality and quantity of DNA isolated.  
 
 
3.4 Transduction of REFs 
 
REFs were isolated form E14.5 rat embryos and used in subsequent transduction experiments as 
they should be easier to reprogram and form iPSCs, which would then give an indication whether the 
culturing method would potentially work for ADSCs and DPSCs. Initially, REFs were transduced and 
cultured in the iPSCs medium (Fig. 4, A), which confirmed the finding with ADSCs and DPSCs that 
iPSCs could not be generated using that medium. REFs demonstrated a propensity to form colonies 
(Fig. 12, B, E, G, H, J and K); however the colonies did not have an iPSC morphology or stained for 
alkaline phosphatase (Fig. 12, H and K). Similar to the ADSCs, the majority of the REFs detached from 
the culture dish between day 18 and day 20.  
1          2         3         4           5         6
1000 bp
500 bp
Figure 11: Confirmation by PCR of STEMCCA integration into genome of lentiviral infected cells. A 
product of approximately 600 bp is observed for the lentivirally infected cells. Lane 1, 1 kb plus 
ladder; lane 2, ADSCs; lane 3, DPSCs; lane 4, ADSCs infected with STEMCCA virus; lane 5, DPSCs 
infected with STEMCCA virus; lane 6, PCR control.  
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3.5 Supplementation of iPSC media with Ascorbic Acid and Lithium chloride 
 
Previous research has shown that supplementation of media with additives can improve the 
reprogramming efficiency[55, 68, 70], therefore REFs (Figs. 13 and 14), ADSCs (Fig. 15) and DPSCs (Fig. 
16) were grown in iPSC media supplemented with just ascorbic acid (Fig. 13) or with ascorbic acid 
and lithium chloride(Fig. 14-16)[55, 68]. The iPSC media supplemented with ascorbic acid or the 
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Figure 12: REFs derived from E14.5 embryos transduced with the STEMMCCA virus and cultured in 
iPSC medium. A-C and G-I; Uninfected control REFs; D-F and J-L, REFs infected with the STEMCCA 
virus. Images show transduced cells at days 4 (A and D), 6 (B and E), 10 (C and F) and 18 (G and J). 
REFs were stained with alkaline phosphatase on day 20 (H, I, K, and L).  Scale bars represent 100 µm 
for A-H, J and K and 1 cm for I and L. Arrows indicate colony formation.  
27 
 
combination of ascorbic acid and lithium chloride was unable to support or promote the derivation 
of iPSCs (Figs. 13, 14 and 16, H, I, K and L; 15, I and J), however colonies formed again (Figs. 13, G, H, 
J and K; 14, D-H, J and K; 15, D-F).  
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Figure 13: REFs cultured in iPSC medium supplemented with ascorbic acid after viral transduction. 
A, B, C, G, H and I; Control REFs that were not transfected with the STEMCCA virus. D, E, F, J, K, and L; 
REFs when infected with the STEMCCA virus. Images show transduced cells at days 4 (A and D), 6 (B 
and E), 10 (C and F) and 18 (G and J). REFs were stained with alkaline phosphatase on day 20 (H, I, K, 
and L).  Scale bars represent 100 µm for A-H, J and K and 1 cm for I and L. Arrows indicate colony 
formation.  
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Figure 14: REFs cultured in iPSC medium supplemented with ascorbic acid and lithium chloride 
following viral transduction. A-C and G-I; Control REFs; D-F and J-L, REFs lentivirally transduced with 
the STEMCCA and cultured in iPSC medium supplemented with the additives ascorbic acid and 
lithium chloride. Images show REFs at days 4 (A and D), 6 (B and E), 10 (C and F) and 18 (G and J). 
REFs were stained with alkaline phosphatase on day 20 (H, I, K, and L). Scale bars represent 100 µm 
(A-F, G, H J and K) and 1 cm (I and L). Arrows show colonies that have formed.  
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Figure 15: ADSCs cultured in iPSC medium supplemented with ascorbic acid and lithium chloride. 
Lentivirally infected (D-F and H-I) and control ADSCs (A-C and G). ADSCs shown from day 5 (A and D), 
9 (B and E), 17 (C and F) and 21 (G-J). Cells stained for alkaline phosphatase (I and J). Images of the 
control ADSCs stained for alkaline phosphatase are not shown due to cells dissociating from culture 
dish. Arrows indicate colonies and scale bars represent 100 µm (A-I) and 1 cm (J).  
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3.6 Using the inhibitors CHIR-99021 and PD-0325901 
 
The inhibitors CHIR-99021 and PD-0325901 were added to the iPSC medium as they had previously 
been used to generate iPSCs [19]. REFs formed colonies after 6 days post-transduction (Fig. 17, B and 
F), with a typical iPSC morphology being observed after 8 days (Fig. 17, F). The colonies stained 
intensely for alkaline phosphatase and could be seen with the naked eye on the culture dish. ADSCs 
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Figure 16: Culturing of DPSCs in iPSC medium supplemented with ascorbic acid and lithium chloride 
after lentiviral infection. DPSCs without lentiviral infection (A-C and G-I) and DPSCs infected with 
STEMCCA virus (D-E and J-K) from day 5 (A and D), 9 (B and E), 17 (C and F) and 21 (G-L). Cells stained 
for alkaline phosphatase (H, I, K and L). Scale bars: 100 µm (A-H, J and K) and 1 cm (I and L).  
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and DPSCs were also cultured in iPSC medium with the addition of the two inhibitors without, 
however without success of generating iPSC colonies (Figs 19 and 21).  
 
 
A
FED
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Figure 17: Derivation of presumptive riPSCs from REFs by viral transduction and culturing in 2i 
media. A-C and G-I, Control REFs that were not infected with the STEMCCA virus; D-F and J-L, REFs 
infected with the STEMCCA virus. Images show cells at days 0 (A and D), 6 (B and E), and 8 (C and F). 
REFs were stained for alkaline phosphatase on day 9 (G - L).  Scale bars represent 100 µm for A-H, J 
and K and 1 cm for I and L. Arrows indicate colony formation. 
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Cultures of REFs, ADSCs and DPSCs were simultaneously transduced and grown in iPSC media 
containing the two inhibitors with the addition of ascorbic acid and lithium chloride to see if this 
would increase the efficiency of iPSC derivation (Figs. 18, 20 and 22). Colonies formed but did not 
show the iPSC morphology previously seen in the REF culture with just the two inhibitors added (Fig. 
18, B, C F and H). Confirmation by staining for alkaline phosphatase showed that iPSC colonies did 
A
FED
CB
G
LKJ
IH
Figure 18: Transduction of REFs using the STEMCCA virus and culturing in 2i media supplemented 
with ascorbic acid and lithium chloride. A-C and G-I, Control REFs; D-F and J-L, STEMCCA virus 
infected REFs. Images show cells at days 0 (A and D), 6 (B and E), and 8 (C and F). REFs were stained 
with alkaline phosphatase on day 9 (G - L).  Scale bars in A-H, J and K indicate 100 µm, and 1 cm in I 
and L. Arrows indicate colony formation. 
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not form (Figs. 18, 20 and 22, G-L). Ascorbic acid and lithium chloride combined with the iPSC media 
and two inhibitors did not improve the outcome for the ADSCs and DPSCs with no iPSC colonies 
forming (Figs. 20 and 22).  
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Figure 19: Culturing of ADSCs in iPSC medium containing the two inhibitors. ADSCs failed to form 
iPSC colonies when infected with the STEMCCA virus (D-F, I and J). Control cultures show ADSCs 
grown without viral transduction (A-C, G and H). Cells shown from days 0 (A and D), 6 (B and E), 14 (C 
and F) and stained for alkaline phosphatase on 21 (G-J). Scale bars represent 100 µm (A-G and I) and 
1 cm (H and J). Arrow show potential colony formation.  
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Figure 20: ADSCs cultured in iPSC medium containing 2i, ascorbic acid and lithium chloride. ADSCs 
infected with the STEMCCA virus (D-F, I and J) and control cultures of ADSCs (A-C, G and H). Cells 
shown from days 0 (A and D), 6 (B and E), 14 (C and F) and 21 (G-J). Staining for alkaline phosphatase 
(G-J). Scale bars represent 100 µm (A-G and I) and 1 cm (H and J). Arrow show colony formation. 
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Figure 21: Culturing of DPSCs with CHIR-99021 and PD-0325901 in iPSC media. DPSCs lentivirally 
transduced (D-F, I and J) and control cells (A-C, G and H) from the day of infection (A and D), day 6 (B 
and E), day 14 (C and F) and day 21 (G-J). Alkaline phosphatase expression in DPSCs (G-J). 100 µm (A-
G and I) and 1 cm are represented by the scale bars.  
37 
 
 
 
 
 
 
BA C
D E F
G H
I J
Figure 22: Attempted derivation of riPSCs from DPSCs using iPSC media supplemented with 2i, 
ascorbic acid and lithium chloride.  DPSCs transduced with the STEMCCA (D-F, I and J) and control 
cells (A-C, G and H) from the day of infection (A and D), day 6 (B and E), day 14 (C and F) and day 21 
(G-J). G-J, Cells stained for the expression of alkaline phosphatase. 100 µm (A-G and I) and 1 cm are 
represented by the scale bars. 
38 
 
4. Discussion: 
 
Presumptive riPSCs were successfully generated from REFs using the STEMCCA lentivirus delivery 
system when cultured in iPSC media supplemented with the two inhibitors CHIR-99021 and PD-
0325901 (Fig. 17), however further characterisation is necessary to demonstrate whether the 
colonies observed are bona fide iPSCs. riPSCs could not be generated from DPSCs or ADSCs using the 
same culturing conditions (Fig. 19 and 21).  
The two inhibitors, CHIR-99021 and PD-0325901, have previously been demonstrated to be essential 
components of the culture media used to derive riPSCs[19, 63, 64, 66], in addition to being required to 
isolate and culture rESCs[75, 76]. CHIR-99021 inhibits glycogen synthase kinase 3β (GSK3β) which is 
involved in the wnt-signalling pathway. The role of wnt-signalling in ESCs and therefore iPSCs is a 
contentious issue with evidence supporting both a role in promoting differentiation as well as 
maintaining stem cell potency through enhanced expression of nanog[77, 78]. The inhibitor, CHIR-
99021, however has been demonstrated to promote reprogramming in a dose dependent 
response[79]. PD-0325901 is an inhibitor of MAPK/ERK kinase (MEK)[80], which is involved in apoptosis, 
cell proliferation, differentiation, motility, metabolism and survival[81]. In ESCs inhibition of MEK 
prevents differentiation and promotes ESC growth and self-renewal[82]. Together the two inhibitors 
are now used extensively to culture and derive ESCs and iPSCs respectively[83].  
The protocol using the two inhibitors in the iPSC medium was unable to generate riPSCs from the 
DPSCs or ADSCs, even though riPSCs were able to be generated from REFs using the same culture 
condition. Reprogramming adult cells has previously been demonstrated to take longer than 
reprogramming embryonic cells which could explain why iPSCs were not derived from ADSCs and 
DPSCs. The ADSCs and DPSCs failed to form iPSC colonies when cultured for up to 21 days after the 
viral transduction, which should, based on previous studies, be sufficient time to reprogram ADSCs 
and DPSCs [71, 84, 85]. The culture conditions may therefore require modifications to promote the 
derivation of iPSCs from ADSCs and DPSCs, which could include additional supplements or inhibitors 
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being added to the media. The DPSCs stained moderately for alkaline phosphatase (Figs. 8, 16, 21 
and 22) regardless of whether reprogramming had taken place, demonstrating that alkaline 
phosphatase expression is not exclusive to iPSCs and that further characterisation is required to 
demonstrate cells have become iPSCs. The ADSCs in particular proved difficult to culture for 
prolonged periods without passaging and frequently dissociated from the culture dish. It may be 
preferable with ADSCs to culture using a feeder layer and ESC media as this represses the growth of 
somatic cells while promoting the growth of iPSCs, which would circumvent the problems with the 
ADSCs becoming overly confluent and dissociating from the dish. In ADSCs and DPSCs cultures, 
colonies with a non-ESC like morphology were frequently observed which has previously been 
described in the literature[71]. 
The other culture conditions used (iPSC media, ascorbic acid and lithium chloride supplementation 
and seeding onto a feeder layer) were unable to generate iPSC colonies from either the REFs, ADSCs 
or DPSCs. This was possibly due to the fundamental requirement of the two inhibitors to derive and 
culture riPSCs. Interestingly, when ascorbic acid and lithium chloride (previously shown to improve 
reprogramming and iPSC derivation) were also supplemented along with the two inhibitors, no iPSC 
colonies formed from the REFs (Fig. 18). This suggested either ascorbic acid and/or lithium chloride 
were incompatible with riPSC derivation and/or that they abrogated the effect of the two inhibitors. 
Lithium chloride can also inhibit GSK3β, which could mean that lithium chloride and CHIR-99021 are 
competitive inhibitors therefore reducing their efficacy to inhibit GSK3β. Ascorbic acid on the other 
hand has been shown to enhance differentiation of stem cells, including ESCs, which could impede 
reprogramming, however independent groups have had success with deriving iPSCs with media 
supplemented with ascorbic acid. Why ascorbic acid has these contrary effects is hitherto unknown 
due to the complex interactions ascorbic acid produces in cells. This shows that the culture media is 
vital in successfully reprogramming cells and generating iPSCs. Further research is required to 
optimise the culture media used to derive riPSCs, which may be different from that used for miPSCs 
and hiPSCs derivation.  
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iPSC colonies took longer to generate from REFs, isolated from E14.5 embryos, when compared with 
iPSCs colonies derived from MEFs at the same embryonic stage. This could have been due to the 
culture and transduction conditions not being optimised to efficiently generate riPSCs, or could be 
due to fundamental differences between MEFs and REFs. The STEMCCA is composed of mouse 
OSKM genes, which could account for iPSCs taking a shorter time to derive from MEFs compared 
with REFs. Genes involved in pluripotency are highly conserved[86, 87], with the majority of iPSC 
derivation using either mouse or human OSKM genes, regardless of the species the iPSCs are being 
derived from[11, 19, 21, 62, 88]. Mouse LIF was added to the reprogramming media which again even 
though highly conserved (greater than 90 %; Blastp[89], accession numbers NP_032527 (mouse LIF) 
and NP_071532 (rat LIF)) could contribute to the extended time required to reprogram rat cells.  
ADSCs and DPSCs may also be difficult to reprogram using the STEMCCA virus due to the 
stoichiometry of OSKM being inefficient or unfavourable to the reprogramming process. The 
STEMCCA virus is designed to produce the OSKM factors at levels to efficiently reprogram cells, 
however ADSCs and DPSCs have been demonstrated to express some of these factors endogenously 
which could affect the reprogramming efficiency. DPSCs have been shown to express Oct4, Sox2, c-
Myc and Nanog [90-92] whereas ADSCs have been shown to expressOct4, Sox2, Klf4, c-Myc and other 
embryonic genes such as Rex1[93]. Other papers have derived iPSCs from ADSCs or DPSCs using 
vectors which deliver the reprogramming factors individually thus allowing for the levels of vectors 
added to be modified.  
Further work is required to determine a media that supports riPSC derivation from ADSCs and 
DPSCs. Once riPSCs have been derived from ADSCs they will need to be characterised for future work 
which could include assessment of the suitability of iPSCs derived from ADSCs and DPSCs for use in 
regenerative therapies.  
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5. Conclusion 
 
A method of generating riPSCs has been developed using the STEMCCA lentivirus delivery system. 
The media requires the addition of two inhibitors; CHIR-99021, which inhibits GSK-3β and PD-
0325901, a MEK inhibitor. riPSCs were able to be derived from REFs, but hitherto unable to be 
derived from rat ADSCs or DPSCs. Subsequent work will require a method of deriving iPSCs form 
ADSCs and DPSCs and the riPSCs will need to be characterised for future use.  
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7. Supplementary Data 
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Figure S1: ADSCs infected with the STEMCCA virus and cultured in DMEM based iPSC media. Cells 
shown from days 0 (A), 5 (B), 7 (C), 9 (D), 11 (E), 23 (F), 27 (G) and stained for alkaline phosphatase on 
day 29 (H and I). Arrows show colony formation. Scale bars: 100 µm (A-H) and 1 cm (I).  
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Figure S2: DPSCs infected and grown in DMEM based iPSC media. DPSCs shown from days 0 (A), 5 
(B), 7 (C), 11 (D), 13 (E), 15 (F), 23 (G) and stained for alkaline phosphatase on day 29 (H and I). 
Arrows show colony formation. Scale bars: 100 µm (A-H) and 1 cm (I). 
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Figure S3: ADSCs cultured in ESC media without being seeded onto irradiated MEF feeder layer. 
Images are from day 7 (A and D), day 9 (B and E), day 14 (C and F) and the cultures were stained on 
day 21 for alkaline phosphatase (G-J). 
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Figure S4: DPSCs cultured in ESC media without being seeded onto irradiated MEF feeder layer. 
Images are from day 7 (A and D), day 9 (B and E), day 14 (C and F) and the cultures were stained on 
day 21 for alkaline phosphatase (G-J). 
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